Memphasys Limited Discloses Expiry of 488 Million Unexercised Options in November 2026

Manish Choudhary

11 November 2026 02:06 PM AEDT

Memphasys Limited Discloses Expiry of 488 Million Unexercised Options in November 2026

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Memphasys Limited (ASX:MEM) has notified the exchange of the cessation of two classes of unquoted options totalling 488,087,500 securities, following their expiry without exercise or conversion on 5 November and 8 November 2026.

Key Points

479,754,167 options under code MEMAX, with an exercise price of $0.011, expired on 5 November 2026 without exercise or conversion.
8,333,333 options under code MEMAY, also with an exercise price of $0.011, expired on 8 November 2026 without exercise or conversion.
No consideration was paid by the entity for the cessation of either class of securities.
Following the cessations, Memphasys has 3,095,233,743 ordinary fully paid shares on issue.

Details of Option Classes That Have Ceased

According to the filing, the MEMAX options carried an expiry date of 5 November 2026 and an exercise price of $0.011. A total of 479,754,167 of these unquoted equity securities ceased on that date due to expiry without exercise or conversion. The MEMAY options, also carrying an exercise price of $0.011, numbered 8,333,333 and ceased on 8 November 2026 for the same reason. The company confirmed it paid no consideration in connection with the cessation of either class of options. Both classes now show a remaining balance of zero securities on issue.

Issued Capital Following the Cessations

The filing sets out the company's capital structure following the cessations. Memphasys has 3,095,233,743 ordinary fully paid shares quoted on the exchange. Among unquoted equity securities remaining on issue, the company lists 212,583,334 options expiring 16 April 2027 at $0.011, 7,933,333 options expiring 20 December 2026 at $0.011, 13,392,584 options expiring 15 February 2027 at $0.0149, and 7,000,000 options expiring 15 January 2027 at $0.006, among other classes. The company also has 4,500,000 performance rights and 3,000,000 convertible notes on issue.

Additional Unquoted Options and Performance Rights on Issue

The company's disclosure also details further unquoted option classes with December 2027 expiry dates. These include 6,500,000 options at $0.004 under code MEMAAC, 8,500,000 options at $0.005 under MEMAAD, and 15,000,000 options at $0.007 under MEMAAE. Separately, options under codes MEMAD, MEMAE, and MEMAF, all expiring 19 December 2027, carry exercise prices of $0.004, $0.005, and $0.007, with 6,500,000, 8,500,000, and 10,000,000 securities on issue respectively. Performance rights under code MEMAAF total 4,500,000 securities.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.